Clinical Trials Logo

Bradyarrhythmia clinical trials

View clinical trials related to Bradyarrhythmia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05997004 Completed - Cardiac Arrest Clinical Trials

Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the incidence of bradycardia during laparoscopic cholecystectomy. The main question[s] it aims to answer are: - Does bradycardia really occurs during pneumoperitoneum/laparoscopic surgery? - If the patient get Glycopyrrolate, Does it really prevent pneumoperitoneum/laparoscopic surgery induced bradycardia?

NCT ID: NCT05357716 Completed - Atrial Fibrillation Clinical Trials

Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial

PRE-ALERT
Start date: November 15, 2020
Phase:
Study type: Observational

The clinical study is intended to implement and test the collection and analysis of paired ECG data from the HeartWatch and two comparator devices, an Event Recorder and Holter. The HeartWatch is indicated for extended diagnostic evaluation of patients with transient symptoms of possible cardiac origin such as syncope and palpitations, as well as patients at risk for arrhythmias, but without significant symptoms. While the use of the device itself can be managed by both healthcare professionals and patients, interpretation of the collected data for diagnosis is restricted to healthcare professionals, as the data must be loaded and analyzed separately after recording. Patients indicated for extended ambulatory ECG testing will be approached for participation. Subjects will wear the HeartWatch and an Event Recorder for up to 72 hours or the HeartWatch and Holter monitor for up to 48 hours. Subjects will be asked to document their activities (standing, sitting, walking, exercise, or laying down). Event recorder subjects will collect user-triggered and auto-triggered data, while Holter subjects will record diary information on their activities and any relevant symptoms. Adverse events and user preference for one device versus the other being used in that arm will also be collected from all subjects. Paired ECG data from the HeartWatch and comparator devices is expected to be similar in terms of the events documented and the proportion of data that is clinically interpretable.

NCT ID: NCT02930980 Completed - Bradyarrhythmia Clinical Trials

Micra Accelerometer Sensor Study 2

MASS2
Start date: October 14, 2016
Phase: N/A
Study type: Interventional

The purpose of the MASS2 is to characterize accelerometer signals of Micra implantable device during different postures and activities and to understand the source of the sensed motion, in order to test feasibility for future enhancements in device functionalities.

NCT ID: NCT01897558 Completed - Bradyarrhythmia Clinical Trials

Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes

PACMAN
Start date: April 2013
Phase: N/A
Study type: Interventional

Pacemaker electrodes are either equipped with tines (passive fixation) or with a screw (active fixation) for initial fixation in the patient´s heart. Both types of electrodes provide similar results in a long-term follow-up and the use of one or the other electrode type in many instances is mainly based on the implanter´s preference. The PACMAN-trial investigates whether the two lead types are associated with different amounts of myocardial micro-damage during implantation.

NCT ID: NCT01715558 Completed - Bradyarrhythmia Clinical Trials

Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2

OPTI-MIND 2
Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of the study is to demonstrate that reduction of unnecessary pacing provided by RYTHMIQ algorithm programed to ON in a pacemaker is associated with better clinical outcomes in bradycardia target population.

NCT ID: NCT01523704 Completed - Bradyarrhythmia Clinical Trials

Safety and Efficacy Study of IPG Patient With Home Monitoring

Start date: January 2012
Phase: N/A
Study type: Interventional

The number of patients with implantable pulse generator (IPG) has steadily increased in Japan causing increment in number of in office follow-ups and greater burden on many hospitals. The purpose of this multicenter randomized study is to demonstrate that BIOTRONIK Home Monitoring system reduces office follow-up visits without compromising patient safety.

NCT ID: NCT01522755 Completed - Bradyarrhythmia Clinical Trials

Predictive Factors of a Successful Implant of the CapsureFix MRI Model 5086

Start date: May 2011
Phase:
Study type: Observational

Pacing leads are key elements of a pacing system as their proper functioning is one of the major factors affecting the long term performance of the whole system. Success of a pacing lead implant can be defined considering 3 items: ease of lead implant, lead stability and lead electrical performances. These factors may be related to the physician experience (global implant experience, experience with a given lead), to the implant procedure (lead access, lead position, implant time, scopy time) to the lead (handling and mechanical characteristics) and to the patient (ischemic history). Even though implant success rate is quite high with currently available leads, the weight of the different factors influencing success has never been studied systematically. The objective of the current study is then to define the predictive factors of an implant success with the CapsureFix MRI model 5086. This lead has been selected because it has been available for a short period, so the investigators have a limited experience of it and it has a unique design which makes it conditionally safe in an MRI environment and which may be associated with specific handling characteristics.

NCT ID: NCT01513538 Completed - Bradyarrhythmia Clinical Trials

Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function

Start date: May 2011
Phase: N/A
Study type: Observational

The technological progress allowed the development of more and more sophisticated pacemakers, widening the therapeutic indications but also meeting the physiological needs of the patient. This progress led to a more and more complex programming for the physicians. To help them set optimally the pacing parameters, physicians refer to the existing recommendations of learned societies as well as to his expertise. Manufacturers developed also algorithms integrated into pacemakers with the aim of assisting physicians in their programming. TherapyGuide is a function which proposes a programming adapted to the psychopathological state of the patient, with a justification based on experts' consensus, clinical studies as well as on published articles. Physicians have the choice to accept or reject the programming proposed by TherapyGuide. When rejected, there is no means to analyze the modifications brought to the proposed set of parameters. The nature, the frequency and the reasons of these modifications are not thus known. The purpose of this study is to assess the acceptance of the TherapyGuide proposals by physicians and to identify the most frequent type of programming changes they make and their rationale.

NCT ID: NCT01089634 Completed - Clinical trials for Ventricular Tachycardia

Left Ventricular Capture Management Study

LEARN
Start date: October 2007
Phase:
Study type: Observational

Primary Objective: To characterize left ventricular (LV) threshold behavior over time using daily left ventricular capture management (LVCM) measurements. Study Design: This is a multicenter, prospective, non-interventional study with patients receiving their first cardiac resynchronisation therapy-implantable cardioverter defibrillator (CRT-ICD) device. The study design, based on the primary objective, is an observational examination of LV thresholds over time. Daily left ventricular threshold measurements will be collected using the LVCM feature. Up to 150 patients will be enrolled in Canada to evaluate the primary objective at up to 15 study centers. Data will be collected at Baseline, Implant, 12 months post-implant and all regularly scheduled follow-up visits up to 12 months post-implant. Devices: The ConcertoTM CRT-ICD device and future Medtronic CRT-ICD devices containing the LVCM feature will be used in this study.

NCT ID: NCT00976482 Completed - Bradyarrhythmia Clinical Trials

Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications

OPTI-MIND
Start date: September 2009
Phase: N/A
Study type: Observational

The study objective is to collect mid-term clinical outcome in a group of patients implanted with permanent pacemaker (PM) according to real-life clinical practice in a multicenter and international environment.